BioSyent Releases Q2 and Six Month Results-Q2 Sales Increase 72%, Net Income After Tax Up 112%
August 21, 2014 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - Aug. 21, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its Second Quarter (Q2 2014) and first half (H1 2014) financial...
BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For New Urgent Care Drug Product
July 23, 2014 09:43 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - July 23, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive...
BioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
June 13, 2014 17:12 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - June 13, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that CEO René Goehrum will be making a presentation at the 2014 Bloom...
BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608%
June 12, 2014 16:01 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - June 12, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that Canadian Business and PROFIT has ranked BioSyent as one of...
BioSyent Pharma Receives Health Canada Approval to Market New Urgent Care Product
June 12, 2014 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - June 12, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has received Health Canada -...
BioSyent Annual General Meeting of Shareholders - June 10, 2014
June 06, 2014 08:16 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - June 6, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that it will be holding its Annual General and Special Meeting of...
BioSyent to Present at the 2014 Marcum MicroCap Investor Conference
May 23, 2014 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 23, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that CEO René Goehrum will be making a presentation at the Marcum...
BioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal Suppositories
May 21, 2014 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 21, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of...
BioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%
May 16, 2014 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 16, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its First Quarter (Q1 2014) financial results. Key highlights...
BioSyent Releases Q4 and Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales Increase 61%
March 12, 2014 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - March 12, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its Fiscal 2013 and Fourth Quarter (Q4 2013) financial results....